Workflow
本土臻造 互作领航——赛多利斯Octet 分子互作分析系统在华投产

Core Insights - Sartorius has launched the Octet molecular interaction analysis system at its Shanghai facility, marking a new phase in the localization of high-end molecular interaction analysis systems [1][3] - The Octet system, utilizing Bio-Layer Interferometry (BLI) technology, has supported nearly 10,000 research institutions and pharmaceutical companies globally, resulting in approximately 20,000 published articles, including over 300 in CNS journals [1] - The localized production of Octet instruments includes three main models: dual-channel, four-channel, and eight-channel, aimed at enhancing supply chain resilience and improving response times for local customers [1] Company Strategy - Sartorius emphasizes strict quality standards in its Shanghai factory, ensuring that every locally produced Octet system meets the same performance and stability as those produced at its headquarters [4] - The local production is a key initiative to respond to market demands in China and represents an important step in Sartorius's global strategic layout, enabling faster and more tailored services [4] - The company views the production of the Octet system in China as a recognition of the potential of the Chinese life sciences market, aiming to leverage cost advantages and improved delivery speeds to foster collaboration with local customers [6] Market Vision - Sartorius aims to accelerate medical discoveries and simplify drug production by integrating German precision manufacturing with local innovation needs, establishing a localized development path characterized by technology empowerment and shared value [8]